Histologic characteristics and local cellular immunity of the gland of the third eyelid after topical ophthalmic administration of 2% cyclosporine for treatment of dogs with keratoconjunctivitis sicca

Celal Izci Department of Clinical Sciences, College of Veterinary Medicine, University of Selcuk, 42031, Campus, Konya/Turkey.

Search for other papers by Celal Izci in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Ilhami Celik Department of Histology and Embryology, College of Veterinary Medicine, University of Selcuk, 42031, Campus, Konya/Turkey.

Search for other papers by Ilhami Celik in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Fahrettin Alkan Department of Clinical Sciences, College of Veterinary Medicine, University of Selcuk, 42031, Campus, Konya/Turkey.

Search for other papers by Fahrettin Alkan in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Zeki Ogurtan Department of Clinical Sciences, College of Veterinary Medicine, University of Selcuk, 42031, Campus, Konya/Turkey.

Search for other papers by Zeki Ogurtan in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Cengiz Ceylan Department of Clinical Sciences, College of Veterinary Medicine, University of Selcuk, 42031, Campus, Konya/Turkey.

Search for other papers by Cengiz Ceylan in
Current site
Google Scholar
PubMed
Close
 DVM
,
Emrah Sur Department of Histology and Embryology, College of Veterinary Medicine, University of Selcuk, 42031, Campus, Konya/Turkey.

Search for other papers by Emrah Sur in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
, and
Yasemin Ozkan Department of Histology and Embryology, College of Veterinary Medicine, University of Selcuk, 42031, Campus, Konya/Turkey.

Search for other papers by Yasemin Ozkan in
Current site
Google Scholar
PubMed
Close
 DVM

Click on author name to view affiliation information

Abstract

Objective—To evaluate the efficacy of topical administration of a 2% solution of cyclosporine (CsA) for treatment of dogs with keratoconjunctivitis sicca (KCS) and to correlate results with histopathologic characteristics and local cellular immunity of the gland of the third eyelid.

Animals—24 dogs with bilateral KCS.

Procedure—Lacrimal secretion was measured, using Schirmer tear test (STT) strips. Leukocyte and T-lymphocyte subsets were determined in blood samples. Histopathologic changes as well as CD4+, CD8+, and alpha-naphthyl-acetate esterase-positive (ANAE+) lymphocytes were evaluated.

Results—Clinical signs resolved at the end of 1 month in conjunction with significantly increased STT values, compared with baseline values. Fifteen and 30 days after discontinuation of CsA treatment, a decrease was observed in STT values in both eyes; however, only values for the right eye were significantly different. There was a significant decrease in the number of lymphocytes and ANAE+ lymphocytes 15 and 30 days after discontinuation of CsA treatment, compared with baseline values. Differences were not observed in number of CD4+ lymphocytes among treatment groups. However, there was a significant decrease in number of CD8+ lymphocytes with reversal of the CD4+:CD8+ in both eyes after CsA treatment for 30 days, compared with the control group. Increased secretory activity and decreased lymphocyte infiltration were characteristic histopathologic findings.

Conclusions and Clinical Relevance—Topical administration of a 2% solution of CsA was effective for the treatment of dogs with KCS. Strict follow-up monitoring is required after the cessation of treatment because of the possibility of recurrence of KCS. (Am J Vet Res 2002;63:688–694)

Abstract

Objective—To evaluate the efficacy of topical administration of a 2% solution of cyclosporine (CsA) for treatment of dogs with keratoconjunctivitis sicca (KCS) and to correlate results with histopathologic characteristics and local cellular immunity of the gland of the third eyelid.

Animals—24 dogs with bilateral KCS.

Procedure—Lacrimal secretion was measured, using Schirmer tear test (STT) strips. Leukocyte and T-lymphocyte subsets were determined in blood samples. Histopathologic changes as well as CD4+, CD8+, and alpha-naphthyl-acetate esterase-positive (ANAE+) lymphocytes were evaluated.

Results—Clinical signs resolved at the end of 1 month in conjunction with significantly increased STT values, compared with baseline values. Fifteen and 30 days after discontinuation of CsA treatment, a decrease was observed in STT values in both eyes; however, only values for the right eye were significantly different. There was a significant decrease in the number of lymphocytes and ANAE+ lymphocytes 15 and 30 days after discontinuation of CsA treatment, compared with baseline values. Differences were not observed in number of CD4+ lymphocytes among treatment groups. However, there was a significant decrease in number of CD8+ lymphocytes with reversal of the CD4+:CD8+ in both eyes after CsA treatment for 30 days, compared with the control group. Increased secretory activity and decreased lymphocyte infiltration were characteristic histopathologic findings.

Conclusions and Clinical Relevance—Topical administration of a 2% solution of CsA was effective for the treatment of dogs with KCS. Strict follow-up monitoring is required after the cessation of treatment because of the possibility of recurrence of KCS. (Am J Vet Res 2002;63:688–694)

All Time Past Year Past 30 Days
Abstract Views 42 0 0
Full Text Views 497 263 30
PDF Downloads 232 110 5
Advertisement